Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2022 - 09 - 06 tags : Pharma save search
Cocrystal Pharma to Participate in the H.C. Wainwright Global Investment Conference
Published: 2022-09-06 (Crawled : 19:00) - biospace.com/
COCP | $1.495 -1.39% 7.6K
|
Health Technology
|
| O: 1.41%
H: 0.0%
C: -5.84%
pharma global conference
MEI Pharma to Present at the H.C. Wainwright 24th Annual Global Investment Conference 2022
Published: 2022-09-06 (Crawled : 14:00) - biospace.com/
MEIP | $3.3 1.54% 1.52% 26K
|
Health Technology
|
| O: 1.09%
H: 2.61%
C: -4.27%
pharma global conference
Athira Pharma Provides Update on Plans for Ongoing LIFT-AD Clinical Study of Fosgonimeton in Mild-to-Moderate Alzheimer’s Patients
Published: 2022-09-06 (Crawled : 13:00) - globenewswire.com
ATHA | $2.12 2.91% 2.83% 200K
|
Health Technology
|
| O: 0.61%
H: 0.61%
C: -3.66%
ongoing pharma alzheimer’s update study fosgonimeton
Inozyme Pharma to Present at H.C. Wainwright 24th Annual Global Investment Conference
Published: 2022-09-06 (Crawled : 13:00) - globenewswire.com
INZY | $4.5 -1.75% -1.78% 590K
|
Health Technology
|
| O: -0.99%
H: 1.66%
C: -2.33%
pharma global conference
aTyr Pharma to Present at the H.C. Wainwright 24th Annual Global Investment Conference 2022
Published: 2022-09-06 (Crawled : 13:00) - globenewswire.com
LIFE | $1.6 -1.23% -1.25% 160K
|
Health Technology
|
| O: -0.87%
H: 3.8%
C: 1.46%
pharma global conference
Ocuphire Pharma to Present at The H.C. Wainwright 24th Annual Global Investment Conference
Published: 2022-09-06 (Crawled : 13:00) - globenewswire.com
OCUP | $1.66 -0.6% -0.6% 230K
|
Health Technology
|
| O: 3.59%
H: 0.0%
C: -4.33%
pharma global conference
FDA and Health Canada Clear IND for FSD Pharma to Proceed with Phase 2 Trial of FSD201 for Nociplastic Pain Associated with Idiopathic Mast Cell Activation Syndrome
Published: 2022-09-06 (Crawled : 13:00) - biospace.com/
HUGE | $0.6167 1.22% 29K
|
Process Industries
|
| O: 0.28%
H: 1.96%
C: -1.3%
fsd201 fda pharma canada health trial phase 2
Evoke Pharma to Participate in H.C. Wainwright 24th Annual Global Investment Conference
Published: 2022-09-06 (Crawled : 13:00) - biospace.com/
EVOK | $0.493 2.97% 2.88% 1.9K
|
Health Technology
|
| O: -0.39%
H: 0.07%
C: -4.3%
pharma global conference
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.